Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012 Oct;16(7):1870-6.
doi: 10.1007/s10461-012-0209-y.

HIV incidence in young girls in KwaZulu-Natal, South Africa--public health imperative for their inclusion in HIV biomedical intervention trials

Quarraisha Abdool Karim  1 , Ayesha B M Kharsany, Janet A Frohlich, Lise Werner, Mukelisiwe Mlotshwa, Bernadette T Madlala, Salim S Abdool Karim
Affiliations

HIV incidence in young girls in KwaZulu-Natal, South Africa--public health imperative for their inclusion in HIV biomedical intervention trials

Quarraisha Abdool Karim et al. AIDS Behav. 2012 Oct.

Abstract

Young women are particularly vulnerable for acquiring HIV yet they are often excluded from clinical trials testing new biomedical intervention. We assessed the HIV incidence and feasibility of enrolling a cohort of young women for potential participation in future clinical trials. Between March 2004 and May 2007, 594 HIV uninfected 14-30 year old women were enrolled into a longitudinal HIV risk reduction study in KwaZulu-Natal, South Africa. The overall HIV prevalence at screening in young girls below the age of 18 years was 27.6 % compared to 52.0 % in the women above 18 years, p < 0.001. HIV incidence was 4.7 [95 % Confidence interval (CI) 1.5-10.9) and 6.9 (95 % CI 4.8-9.6)/100 women years (wy), p = 0.42 and pregnancy rates were 23.7 (95 % CI 14.9-35.9) and 16.4 (95 % CI 12.9-20.6)/100 wy, p = 0.29, in the women below and above 18 years respectively. Retention was similar in both groups (71.0 vs. 71.5 %, p = 0.90). This study demonstrates that the inclusion of young girls between the ages of 14 and 17 years in longitudinal studies is feasible and their inclusion in clinical trials would maintain scientific integrity and power of the study.

PubMed Disclaimer

References

    1. World Health Organisation and Joint United Nations Programme on HIV/AIDS. GLOBAL HIV/AIDS RESPONSE- Epidemic update and health sector progress towards Universal Access. 2011 http://whqlibdoc.who.int/publications/2011/9789241502986_eng.pdf.
    1. Gouws E, Stanecki KA, Lyerla R, Ghys PD. The epidemiology of HIV infection among young people aged 15–24 years in southern Africa. AIDS. 2008;22(Suppl 4):S5–S16. - PubMed
    1. Gouws E. Chapter 4: HIV incidence rates in South Africa. In: Abdool Karim SS, Abdool Karim Q, editors. HIV/AIDS in South Africa. 2nd Edition. New York: Cambridge University Press; 2010. pp. 74–84.
    1. Rehle T, Shisana O, Pillay V, Zuma K, Puren A, Parker W. National HIV incidence measures--new insights into the South African epidemic. S Afr Med J. 2007;97:194–199. - PubMed
    1. National Department of Health. The 2010 National Antenatal Sentinel HIV and Syphilis Prevalence Survey in South Africa. 2011

Publication types